Due to the opposite metabolic effects of leptin and adiponectin, the leptin/adiponectin ratio (L/A ratio) has been proposed as a useful marker for metabolic disease, and may be more strongly associated with CVD risk than leptin or adiponectin alone (12, 13). This evidence concerns the gene LEP and metabolic disease.